Insider Transactions in Q2 2022 at Hcw Biologics Inc. (HCWB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
58,856
+27.46%
|
$117,712
$2.46 P/Share
|
|
Jun 13
2022
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,596
+7.29%
|
$15,192
$2.08 P/Share
|
|
Jun 10
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,520
+0.01%
|
$3,040
$2.19 P/Share
|
|
Jun 10
2022
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,500
+10.34%
|
$3,000
$2.13 P/Share
|
|
Jun 09
2022
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+8.0%
|
$2,000
$2.2 P/Share
|
|
Jun 09
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.01%
|
$4,000
$2.25 P/Share
|
|
Jun 08
2022
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+8.7%
|
$2,000
$2.27 P/Share
|
|
Jun 07
2022
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.01%
|
$2,000
$2.31 P/Share
|
|
Jun 07
2022
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+9.52%
|
$2,000
$2.1 P/Share
|
|
Jun 06
2022
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
1,000
+10.53%
|
$2,000
$2.13 P/Share
|
|
Jun 02
2022
|
Rick S. Greene |
BUY
Open market or private purchase
|
Direct |
4,800
+36.33%
|
$9,600
$2.09 P/Share
|
|
May 31
2022
|
Jin An Jiao VP of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
14,570
+13.25%
|
$0
$0.18 P/Share
|